BioXene is a Hawaii-based nano-biotechnology company. Formed in 2004, the company’s mission is the development of the next generation nanobiosensors.

Utilizing BioXene’s proprietary patent-pending platform, BioXene is developing commercial products with distinct competitive advantages over existing products. Our homogeneous non-competitive nano-scale rapid detection assays do not require sample preparation, labeling or washing. Detection occurs in less than an hour and can be performed outside a laboratory without the aid of a skilled lab technician.